Clinical Trial Update: Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of ImCOOH Cream for moderate atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ImCOOH Cream

Snippet

Sponsor: Valletta Health B.V. | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED